News
-
-
PRESS RELEASE
Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
Lonza and Vertex sign a long-term commercial supply agreement for CASGEVY® cell therapy based on CRISPR/Cas9 gene-editing technology. Lonza to manufacture at Geleen, NL facility approved by FDA, EMA, and MHRA -
-
-
PRESS RELEASE
Cipher Pharmaceuticals to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
Cipher Pharmaceuticals Inc to present at Planet MicroCap Showcase: VANCOUVER 2024 on Sep 26, 2024. Interim CEO Craig Mull to host. More info at https://planetmicrocapshowcase.com/ -
-
-
-
PRESS RELEASE
Battery X Metals Announces Amended Agreement with Global Top 20 Ranked University to Accelerate Eco-Friendly Battery-Grade Material Recovery Technology
Battery X Metals extends research partnership with a global Top 20 university to develop eco-friendly battery-grade material recovery tech, supporting clean energy transition -
PRESS RELEASE
EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S CEO Andreas Gerstenmayer resigns from the Executive Board
AT&S CEO Andreas Gerstenmayer resigns from the Executive Board. Agreement reached with the Nomination Committee. Inside information disclosed according to Article 17 MAR